- Home
- KMDA vs ASA Comparison
KMDA vs ASA Comparison
Compare KMDA & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- ASA
- Stock Information
- Founded
- KMDA 1990
- ASA 1958
- Country
- KMDA Israel
- ASA United States
- Employees
- KMDA N/A
- ASA N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- KMDA Health Care
- ASA Industrials
- Exchange
- KMDA Nasdaq
- ASA Nasdaq
- Market Cap
- KMDA 349.1M
- ASA 415.9M
- IPO Year
- KMDA N/A
- ASA N/A
- Fundamental
- Price
- KMDA $6.47
- ASA $30.72
- Analyst Decision
- KMDA Strong Buy
- ASA
- Analyst Count
- KMDA 3
- ASA 0
- Target Price
- KMDA $14.67
- ASA N/A
- AVG Volume (30 Days)
- KMDA 106.2K
- ASA 82.6K
- Earning Date
- KMDA 05-07-2025
- ASA 05-30-2025
- Dividend Yield
- KMDA 3.10%
- ASA 0.16%
- EPS Growth
- KMDA 66.67
- ASA 1102.63
- EPS
- KMDA 0.25
- ASA 6.06
- Revenue
- KMDA $160,953,000.00
- ASA $2,140,037.00
- Revenue This Year
- KMDA $14.01
- ASA N/A
- Revenue Next Year
- KMDA $9.24
- ASA N/A
- P/E Ratio
- KMDA $25.58
- ASA $5.16
- Revenue Growth
- KMDA 12.93
- ASA N/A
- 52 Week Low
- KMDA $4.74
- ASA $16.25
- 52 Week High
- KMDA $9.15
- ASA $31.94
- Technical
- Relative Strength Index (RSI)
- KMDA 49.43
- ASA 66.65
- Support Level
- KMDA $6.36
- ASA $29.94
- Resistance Level
- KMDA $6.57
- ASA $31.94
- Average True Range (ATR)
- KMDA 0.28
- ASA 1.43
- MACD
- KMDA 0.06
- ASA 0.39
- Stochastic Oscillator
- KMDA 76.23
- ASA 97.47
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.